Treatment of Uncomplicated UTI in Women
For uncomplicated cystitis in healthy non-pregnant women, nitrofurantoin monohydrate/macrocrystals 100 mg twice daily for 5 days is the preferred first-line treatment due to minimal resistance, low collateral damage, and efficacy comparable to trimethoprim-sulfamethoxazole 1, 2.
First-Line Options for Uncomplicated Cystitis
The choice between first-line agents should prioritize resistance patterns and collateral damage:
Nitrofurantoin monohydrate/macrocrystals: 100 mg twice daily for 5 days (A-I evidence) 1
- Minimal resistance and ecological damage
- Avoid if early pyelonephritis suspected
Trimethoprim-sulfamethoxazole: 160/800 mg (1 double-strength tablet) twice daily for 3 days 1, 2
- Only use if local resistance rates are <20% (A-I evidence)
- Avoid if used for UTI in previous 3 months
- Clinical cure drops from 84% to 41% when organism is resistant 1
Fosfomycin trometamol: 3 g single dose 1, 2
- Minimal resistance and collateral damage
- Inferior efficacy compared to other first-line agents (A-I evidence)
- Avoid if early pyelonephritis suspected
Pivmecillinam: 400 mg twice daily for 3-5 days 1, 2
- Limited availability (some European countries only)
- Lower efficacy than other recommended agents
Second-Line Alternatives
Fluoroquinolones should be reserved for important uses other than acute cystitis due to collateral damage concerns (A-III evidence) 1:
- Ciprofloxacin, levofloxacin, ofloxacin: 3-day regimens
- Highly efficacious but not recommended as first-line
Beta-lactams (use only when other agents cannot be used) 1:
- Amoxicillin-clavulanate, cefdinir, cefaclor, cefpodoxime-proxetil: 3-7 days
- Generally inferior efficacy and more adverse effects (B-I evidence)
- Never use amoxicillin or ampicillin alone due to poor efficacy and high resistance (A-III evidence) 1
Acute Pyelonephritis (Upper Tract Infection)
Always obtain urine culture and susceptibility testing before initiating therapy (A-III evidence) 1.
Outpatient Treatment (Mild-Moderate Cases)
Oral ciprofloxacin 500 mg twice daily for 7 days is first-line if local fluoroquinolone resistance is ≤10% (A-I evidence) 1:
- Consider initial IV dose of ciprofloxacin 400 mg, ceftriaxone 1 g, or consolidated 24-hour aminoglycoside dose (B-III evidence)
- If fluoroquinolone resistance exceeds 10%, give initial IV ceftriaxone 1 g or aminoglycoside before oral therapy (B-III evidence) 1
Alternative oral regimens 1:
- Levofloxacin 750 mg daily for 5 days (B-II evidence)
- Ciprofloxacin extended-release 1000 mg daily for 7 days (B-II evidence)
Pregnancy Considerations
The provided guidelines explicitly exclude pregnant women from their scope 1. However, based on the 2024 EAU guidelines 2:
- Trimethoprim: Avoid in first trimester
- Trimethoprim-sulfamethoxazole: Avoid in last trimester
- Nitrofurantoin: Generally acceptable (avoid near term)
- Urine culture is mandatory in pregnant women with suspected UTI 2
Critical Decision Points
- Rule out pyelonephritis first: Check for fever, flank pain, costovertebral tenderness
- Assess local resistance patterns: TMP-SMX only if E. coli resistance <20%
- Consider recent antibiotic exposure: Avoid TMP-SMX if used in previous 3 months
- Verify ability to take oral medication: Required for outpatient management
- For pyelonephritis, know local fluoroquinolone resistance: Use alternative if >10%
Common Pitfalls to Avoid
- Do not treat asymptomatic bacteriuria (positive culture without symptoms) - this leads to unnecessary antibiotic use 3
- Do not use fluoroquinolones for simple cystitis - reserve for pyelonephritis or when other options unavailable 1
- Do not use nitrofurantoin or fosfomycin if pyelonephritis suspected - inadequate tissue penetration 1
- Do not prescribe empiric TMP-SMX without knowing local resistance rates - failure rates exceed 50% when organism is resistant 1